PL381356A1 - Sposób wytwarzania stałej postaci dawkowanej - Google Patents

Sposób wytwarzania stałej postaci dawkowanej

Info

Publication number
PL381356A1
PL381356A1 PL381356A PL38135604A PL381356A1 PL 381356 A1 PL381356 A1 PL 381356A1 PL 381356 A PL381356 A PL 381356A PL 38135604 A PL38135604 A PL 38135604A PL 381356 A1 PL381356 A1 PL 381356A1
Authority
PL
Poland
Prior art keywords
dosage form
form production
constant dosage
constant
production
Prior art date
Application number
PL381356A
Other languages
English (en)
Other versions
PL209823B1 (pl
Inventor
Kristin Wannerberger
Hans Lindner
Lars-Erik Olsson
Ann-Elisabeth Svensson
Lars Anders Ragnar Nilsson
Pascal Rene Olivier Danglas
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL381356(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP03029897A external-priority patent/EP1550439B1/en
Priority claimed from US10/746,254 external-priority patent/US7018653B2/en
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL381356A1 publication Critical patent/PL381356A1/pl
Publication of PL209823B1 publication Critical patent/PL209823B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL381356A 2003-12-29 2004-12-28 Sposób wytwarzania stałej postaci dawkowanej desmopresyny PL209823B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin
US10/746,254 US7018653B2 (en) 2003-12-29 2003-12-29 Method for preparing solid dosage form of desmopressin

Publications (2)

Publication Number Publication Date
PL381356A1 true PL381356A1 (pl) 2007-05-28
PL209823B1 PL209823B1 (pl) 2011-10-31

Family

ID=34702338

Family Applications (1)

Application Number Title Priority Date Filing Date
PL381356A PL209823B1 (pl) 2003-12-29 2004-12-28 Sposób wytwarzania stałej postaci dawkowanej desmopresyny

Country Status (14)

Country Link
EP (1) EP1699437B1 (pl)
JP (1) JP4763617B2 (pl)
KR (1) KR100870679B1 (pl)
AU (1) AU2004308670B2 (pl)
BR (1) BRPI0418240A (pl)
CA (1) CA2490601C (pl)
DE (1) DE602004010302T2 (pl)
DK (1) DK1699437T3 (pl)
ES (1) ES2295962T3 (pl)
MX (1) MXPA06007507A (pl)
NZ (1) NZ546817A (pl)
PL (1) PL209823B1 (pl)
RU (1) RU2334505C2 (pl)
WO (1) WO2005063202A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018602A1 (en) * 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
TW391880B (en) * 1994-01-31 2000-06-01 Yamanouchi Pharma Co Ltd An oral soluble type compression moulding and its preparation
JP4290792B2 (ja) * 1999-01-11 2009-07-08 カルピス株式会社 造粒物、その製法及びこれを用いた錠剤
AU771727B2 (en) * 1999-03-03 2004-04-01 Eli Lilly And Company Processes for making pharmaceutical oral ECB formulations and compositions
CA2460132A1 (en) * 2001-10-15 2003-04-24 Roehm Gmbh & Co. Kg Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent
DE60307082D1 (de) * 2002-05-07 2006-09-07 Ferring Bv In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
ATE291419T1 (de) * 2003-04-30 2005-04-15 Ferring Bv Feste dosierungsform mit desmopressin
ATE301990T1 (de) * 2003-07-25 2005-09-15 Ferring Bv Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung

Also Published As

Publication number Publication date
DK1699437T3 (da) 2007-12-27
CA2490601A1 (en) 2005-06-29
EP1699437B1 (en) 2007-11-21
ES2295962T3 (es) 2008-04-16
RU2334505C2 (ru) 2008-09-27
DE602004010302D1 (de) 2008-01-03
WO2005063202A3 (en) 2006-05-18
JP2007517000A (ja) 2007-06-28
KR20060111566A (ko) 2006-10-27
AU2004308670B2 (en) 2007-08-02
WO2005063202A2 (en) 2005-07-14
BRPI0418240A (pt) 2007-04-17
KR100870679B1 (ko) 2008-11-26
EP1699437A2 (en) 2006-09-13
NZ546817A (en) 2010-07-30
PL209823B1 (pl) 2011-10-31
RU2006120954A (ru) 2008-02-10
MXPA06007507A (es) 2007-01-30
DE602004010302T2 (de) 2008-10-16
CA2490601C (en) 2006-05-02
AU2004308670A1 (en) 2005-07-14
JP4763617B2 (ja) 2011-08-31

Similar Documents

Publication Publication Date Title
PL2638891T3 (pl) Sposób wytwarzania produktów farmaceutycznych
EP1745573A4 (en) PROCESS FOR PREPARING 2-DEOXY-BETA-L-NUCLEOSIDES
IL174951A0 (en) Method for the production of amino crotonyl compounds
IL176296A0 (en) Method for the production of an administration form which is secured against misuse
IL181303A (en) METHOD FOR CREATING DIHYDROPROTRIDINONS AND NUMBER OF THESE COMPOUNDS
ZA200605864B (en) Method for the production of methionine
IL171145A (en) Method for the production of telmisartan
PL1512324T3 (pl) Sposób pozbawiania niekorzystnych właściwości smakowo-zapachowych materiałów pochodzących z soi
IL175148A0 (en) Method for the production of fluoromethyl-substituted heterocycles
GB0329439D0 (en) Production of particles
IL189107A0 (en) Method for preparing solid dosage form of desmopressin
GB0514455D0 (en) Method of making structural members
PL1654240T3 (pl) Sposób otrzymywania N-arylomorfolinonów
GEU20041064U (en) Method for production of Matsoni
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
GB0323640D0 (en) Method of production
ZA200406777B (en) Production of abalone
PL355043A1 (pl) Sposób wytwarzania p-oktylofenolu
PL359045A1 (pl) Sposób wytwarzania benzenosulfonianu amlodypiny
PL362957A1 (pl) Sposób wytwarzania bio-membran
PL362261A1 (pl) Sposób wytwarzania sulfonów trichlorowcometylowoarylowych
GB0300050D0 (en) Method of forming electrluminescent devices
GB0227730D0 (en) Novel production of biocompounds
HU0301663D0 (en) Process for producing of coffee-cream
GB0219671D0 (en) Method of manufacture

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
LAPS Decisions on the lapse of the protection rights

Effective date: 20131228